Company news

BeOne Medicines Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Announcement on Appointing Member of Advisory Committee on Commercial and Medical Affairs of Board of Directors

March 21, 2024

Announcement on Progress in Joint Investment with Related Party and Related Transaction

March 5, 2024

Announcement on 2023 Annual Preliminary Earnings Estimate

February 26, 2024

Announcement on Signing Consulting Agreement and Related Transaction

January 23, 2024

Announcement on Initial Public Offering of Restricted Shares under Strategic Allotment for Circulation

December 7, 2023

Announcement on Adjusting Investment Amount of Raised Funds Invested in Investment Subproject Financed by Raised Funds

November 13, 2023

Announcement on Convening 2023 3rd Quarter Performance Meeting

November 6, 2023

Announcement on Voluntary Disclosure of National Institute for Health and Care Excellence's Recommendation of Baiyueze (Zanubrutinib Capsules) for Treatment of Adult Patients with Chronic Lymphocytic Leukemia

October 20, 2023

Announcement on Voluntary Disclosure of Progress in Obtaining Positive Registration of Baize'an (Tislelizumab Injection) in Europe and America

September 19, 2023

← Newer news releases

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks

The 5 newest of 21 decks. Every deck is listed under its year.